172 related articles for article (PubMed ID: 19946338)
41. C-terminal domain of p42 Ebp1 is essential for down regulation of p85 subunit of PI3K, inhibiting tumor growth.
Hwang I; Kim CK; Ko HR; Park KW; Cho SW; Ahn JY
Sci Rep; 2016 Jul; 6():30626. PubMed ID: 27464702
[TBL] [Abstract][Full Text] [Related]
42. Sumoylation of the GTPase Ran by the RanBP2 SUMO E3 Ligase Complex.
Sakin V; Richter SM; Hsiao HH; Urlaub H; Melchior F
J Biol Chem; 2015 Sep; 290(39):23589-602. PubMed ID: 26251516
[TBL] [Abstract][Full Text] [Related]
43. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling.
Lee PS; Chang C; Liu D; Derynck R
J Biol Chem; 2003 Jul; 278(30):27853-63. PubMed ID: 12740389
[TBL] [Abstract][Full Text] [Related]
44. The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.
Li S; Yang C; Hong Y; Bi H; Zhao F; Liu Y; Ao X; Pang P; Xing X; Chang AK; Xiao L; Zhang Y; Wu H
Biol Cell; 2012 May; 104(5):287-96. PubMed ID: 22283414
[TBL] [Abstract][Full Text] [Related]
45. The RNA-binding protein FUS/TLS undergoes calcium-mediated nuclear egress during excitotoxic stress and is required for
Tischbein M; Baron DM; Lin YC; Gall KV; Landers JE; Fallini C; Bosco DA
J Biol Chem; 2019 Jun; 294(26):10194-10210. PubMed ID: 31092554
[TBL] [Abstract][Full Text] [Related]
46. The polycomb repressive complex 2 is a potential target of SUMO modifications.
Riising EM; Boggio R; Chiocca S; Helin K; Pasini D
PLoS One; 2008 Jul; 3(7):e2704. PubMed ID: 18628979
[TBL] [Abstract][Full Text] [Related]
47. The Mdm-2 amino terminus is required for Mdm2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9.
Buschmann T; Lerner D; Lee CG; Ronai Z
J Biol Chem; 2001 Nov; 276(44):40389-95. PubMed ID: 11384992
[TBL] [Abstract][Full Text] [Related]
48. EBP1 protein modulates the expression of human MHC class II molecules in non-hematopoietic cancer cells.
Pisapia L; Barba P; Cortese A; Cicatiello V; Morelli F; Del Pozzo G
Int J Oncol; 2015 Aug; 47(2):481-9. PubMed ID: 26081906
[TBL] [Abstract][Full Text] [Related]
49. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
[TBL] [Abstract][Full Text] [Related]
50. The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.
Ritterhoff T; Das H; Hofhaus G; Schröder RR; Flotho A; Melchior F
Nat Commun; 2016 May; 7():11482. PubMed ID: 27160050
[TBL] [Abstract][Full Text] [Related]
51. Sumoylated SnoN represses transcription in a promoter-specific manner.
Hsu YH; Sarker KP; Pot I; Chan A; Netherton SJ; Bonni S
J Biol Chem; 2006 Nov; 281(44):33008-18. PubMed ID: 16966324
[TBL] [Abstract][Full Text] [Related]
52. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
[TBL] [Abstract][Full Text] [Related]
53. TRIM28 Is an E3 Ligase for ARF-Mediated NPM1/B23 SUMOylation That Represses Centrosome Amplification.
Neo SH; Itahana Y; Alagu J; Kitagawa M; Guo AK; Lee SH; Tang K; Itahana K
Mol Cell Biol; 2015 Aug; 35(16):2851-63. PubMed ID: 26055329
[TBL] [Abstract][Full Text] [Related]
54. The SUMO E3 ligase activity of Pc2 is coordinated through a SUMO interaction motif.
Yang SH; Sharrocks AD
Mol Cell Biol; 2010 May; 30(9):2193-205. PubMed ID: 20176810
[TBL] [Abstract][Full Text] [Related]
55. Expression and Role of the ErbB3-Binding Protein 1 in Acute Myelogenous Leukemic Cells.
Nguyen le XT; Zhu L; Lee Y; Ta L; Mitchell BS
Clin Cancer Res; 2016 Jul; 22(13):3320-7. PubMed ID: 26813358
[TBL] [Abstract][Full Text] [Related]
56. Casein kinase-2-mediated phosphorylation increases the SUMO-dependent activity of the cytomegalovirus transactivator IE2.
Tripathi V; Chatterjee KS; Das R
J Biol Chem; 2019 Oct; 294(40):14546-14561. PubMed ID: 31371453
[TBL] [Abstract][Full Text] [Related]
57. Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification.
Ohshima T; Koga H; Shimotohno K
J Biol Chem; 2004 Jul; 279(28):29551-7. PubMed ID: 15123625
[TBL] [Abstract][Full Text] [Related]
58. HIF-1α SUMOylation affects the stability and transcriptional activity of HIF-1α in human lens epithelial cells.
Han X; Wang XL; Li Q; Dong XX; Zhang JS; Yan QC
Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1279-90. PubMed ID: 25877955
[TBL] [Abstract][Full Text] [Related]
59. SUMO-targeted ubiquitin ligases.
Sriramachandran AM; Dohmen RJ
Biochim Biophys Acta; 2014 Jan; 1843(1):75-85. PubMed ID: 24018209
[TBL] [Abstract][Full Text] [Related]
60. EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance.
Zhang Y; Linn D; Liu Z; Melamed J; Tavora F; Young CY; Burger AM; Hamburger AW
Mol Cancer Ther; 2008 Oct; 7(10):3176-86. PubMed ID: 18852121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]